{"id":"NCT01063881","sponsor":"Janssen Research & Development, LLC","briefTitle":"The Asia-Pacific Flexible Dose Study of Dapoxetine and Patient Satisfaction in Premature Ejaculation Therapy","officialTitle":"The Asia-Pacific Flexible Dose Study of Dapoxetine and Patient Satisfaction in Premature Ejaculation Therapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-05-22","primaryCompletion":"2011-06-14","completion":"2011-06-14","firstPosted":"2010-02-05","resultsPosted":"2012-10-31","lastUpdate":"2024-11-19"},"enrollment":285,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Sexual Dysfunction, Physiological"],"interventions":[{"type":"DRUG","name":"Dapoxetine","otherNames":[]}],"arms":[{"label":"Dapoxetine","type":"EXPERIMENTAL"}],"summary":"The purpose of the study is to measure the efficacy of flexible dosing of dapoxetine in a setting similar to routine clinical practice.","primaryOutcome":{"measure":"The Number of Patients Who Described Their Premature Ejaculation (PE) as At Least \"Slightly Better\" in Response to Dapoxetine Treatment","timeFrame":"Week 12","effectByArm":[{"arm":"Dapoxetine (Week 12)","deltaMin":228,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":9,"exclusionCount":4},"locations":{"siteCount":13,"countries":["Australia","South Korea","Thailand"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":144},"commonTop":["Nausea","Dizziness","Headache","Somnolence","Palpitations"]}}